dc.creator | Damoiseaux J., Dotan A., Fritzler M.J., Bogdanos D.P., Meroni P.L., Roggenbuck D., Goldman M., Landegren N., Bastard P., Shoenfeld Y., Conrad K. | en |
dc.date.accessioned | 2023-01-31T07:50:10Z | |
dc.date.available | 2023-01-31T07:50:10Z | |
dc.date.issued | 2022 | |
dc.identifier | 10.1016/j.autrev.2021.103012 | |
dc.identifier.issn | 15689972 | |
dc.identifier.uri | http://hdl.handle.net/11615/73057 | |
dc.description.abstract | The relation between infections and autoimmune diseases has been extensively investigated. Multiple studies suggest a causal relation between these two entities with molecular mimicry, hyperstimulation and dysregulation of the immune system as plausible mechanisms. The recent pandemic with a new virus, i.e., SARS-CoV-2, has resulted in numerous studies addressing the potential of this virus to induce autoimmunity and, eventually, autoimmune disease. In addition, it has also revealed that pre-existing auto-immunity (auto-Abs neutralizing type I IFNs) could cause life-threatening disease. Therefore, the topic of the 15th Dresden Symposium on Autoantibodies was focused on autoimmunity in the SARS-CoV-2 era. This report is a collection and distillation of the topics presented at this meeting. © 2021 The Author(s) | en |
dc.language.iso | en | en |
dc.source | Autoimmunity Reviews | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85121796333&doi=10.1016%2fj.autrev.2021.103012&partnerID=40&md5=ea5472d197976d78ce1ca1d26585b1fb | |
dc.subject | alpha interferon | en |
dc.subject | autoantibody | en |
dc.subject | autoantigen | en |
dc.subject | phospholipid antibody | en |
dc.subject | prothrombin antibody | en |
dc.subject | thrombocyte factor 4 | en |
dc.subject | autoantibody | en |
dc.subject | virus RNA | en |
dc.subject | antibody response | en |
dc.subject | autoimmune disease | en |
dc.subject | autoimmunity | en |
dc.subject | coronavirus disease 2019 | en |
dc.subject | heparin induced thrombocytopenia | en |
dc.subject | human | en |
dc.subject | molecular mimicry | en |
dc.subject | mucocutaneous lymph node syndrome | en |
dc.subject | nonhuman | en |
dc.subject | pediatric multisystem inflammatory syndrome | en |
dc.subject | Review | en |
dc.subject | Severe acute respiratory syndrome coronavirus 2 | en |
dc.subject | Autoantibodies | en |
dc.subject | Autoimmunity | en |
dc.subject | COVID-19 | en |
dc.subject | Humans | en |
dc.subject | RNA, Viral | en |
dc.subject | SARS-CoV-2 | en |
dc.subject | Elsevier B.V. | en |
dc.title | Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies | en |
dc.type | other | en |